Cabinet papers:
Amendments to prescribing regulations for controlled drugs
Misuse of Drugs Amendment Regulations
Proactive release of the Cabinet material relating to the transitioning of labelling requirements for medicines newly scheduled as controlled drugs under the Misuse of Drugs Act 1975.
These documents provide context around the Government's decision to amend the Therapeutic Products Bill to create an exemption regime for small-scale natural health product producers and remove most obligations for rongoā.
Pharmac is often criticised for not funding enough new medicines and for being too slow to determine which ones it will fund. However, being slow and focused is not proof of being too slow or too focused.
The Statement of Intent (SOI) is published every three years. This document provides an overview of our strategic priorities for the next four years, as well as specific performance targets and measures.
he purpose of the Therapeutic Products Bill is to protect, promote, and improve the health of all New Zealanders.
During 2021 and 2022, the Pharmacy Team from Manatu Hauora - Ministry of Health and Te Whatu Ora – Health New Zealand consulted widely with consumer and whānau groups throughout Aotearoa.
The intent was to provide an opportunity for consumer groups to share their honest experiences of pharmacy with us along with suggestions for things that could be done better.
Cabinet material relating to:
Misuse of Drugs (Classification and Presumption of Supply) Commencement Order 2022 and the Misuse of Drugs (Classification and Presumption of Supply) Amendment Order 2022
Misuse of Drugs Amendment Regulations 2022 and Medicines Amendment Regulations (No 2) 2022.
Cabinet material related to the increase to the Combined Pharmaceutical Budget in the 2023/24 financial year.
HEALTH SERVICES AND SYSTEMS
EQUITY
Exploring the impacts of the health system on minorities within the population, notably including Māori, Pacifica, Asians and LGBTQI.
DRUGS, DEVICE AND DIAGNOSTICS
PUBLIC HEALTH
DIGITAL HEALTH
TE TIRITI